Montana’s plan to become an experimental medical hub just pushed forward. As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers.
A apuração publicada por www.technologyreview.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval.
- Ponto de atenção: montana.
- Ponto de atenção: plan.
- Ponto de atenção: become.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Tech.
Acompanhe a Recifes.net
Entre no Canal do WhatsApp da Recifes.net para receber noticias, bastidores e atualizacoes editoriais diretamente no WhatsApp.
